NEWS: Curebase closes $40M Series B with strategic investment by Gilead. Read about it in TechCrunch, Fierce Biotech, andEndpoints News.

Welcome to the Curebase Resource Center

This is where you'll find all the educational resources you need to learn about our work and mission.

White papers and case studies

white paper

Learn how Curebase is bringing infectious disease studies to patients

Curebase infectious disease trials successfully enroll patients utilizing a new kind of model that meets patients where they are through community healthcare and virtual settings.

white paper

The Ultimate Guide for Selecting a Full-Service DCT Vendor

This comprehensive guide takes you step-by-step through the process of selecting the best full-service decentralized clinical trial (DCT) vendor for your study.

white papers

Learn how metaMe health achieved FDA clearance through Curebase’s end-to-end capabilities

Read about how Curebase employed highly sophisticated decentralized methods in this pivotal trial with a combination of software, virtual site operations, and operations staff support.

white paper

A guide to navigating CNS clinical trials

This comprehensive guide to designing and executing Central Nervous System (CNS) clinical trials touches on common challenges in these types of studies. Learn how DCT tools and best practices from industry standards and FDA recommendations can be used to overcome these issues.

Case Study

Curebase fast tracks recruitment by activating community clinics to enroll patients in Clip Health chlamydia diagnostic study

In 2019, Clip Health was looking to study the accuracy and effectiveness of their SheCares self-administered diagnostic test for Chlamydia. Clip Health’s product vision was to offer healthcare solutions with rapid, accurate, decentralized diagnostics at the core.

Case study

Curebase optimizes patient retention rates in CNS studies by implementing validated engagement tactics

In Curebase’s first international study, Quit Genius, an addiction digital clinic based in the United Kingdom was looking to test the preliminary effectiveness of a novel digital therapeutic intervention for smoking cessation. This treatment tool consisted of a digital therapeutic intervention via a smartphone app that delivered cognitive behavioral therapy, one-on-one coaching, craving tools, and more.


July 7, 2022

DIA 2022 Recap: The value of learning by doing


June 24, 2022

Supporting Women’s health: Addressing gender disparities in clinical trials 


May 25, 2022

How decentralized clinical trial models and technology can address common CNS study challenges


Learn from the experts


August 5, 2022

The Impact of Virtual Sites on Patient Retention and Cost Efficiency in Veteran Populations


August 9, 2022

The Foundations (and Future) of Digital Therapeutics and DCT


August 1, 2022

Comparing Virtual and Traditional Sites in a Pivotal Medical Device Trial

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Subscribe to Curebase content

Get our most recent blogs, whitepapers, webinars and case studies delivered straight to your inbox.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
335 S Van Ness Ave, San Francisco, CA,
94103-3627, United States